Form 4 holding
Director
Brooklyn ImmunoTherapeutics, Inc.
- Security class
- Stock Option
- Shares / value
- 67,000
- Estimated value
- Report date
- 08 Dec 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount